Dyslipidemia: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
== Introduction == | == Introduction == | ||
Dyslipidemia is characterized by an elevation of | Dyslipidemia is characterized by an elevation of low-density lipoprotein cholesterol (LDL-C) and reduced serum high-density lipoprotein cholesterol (HDL-C) concentration.<ref>Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, Lira FS, Gonçalves DC. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962737/ Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol]. Frontiers in Physiology. 2018 May 15;9:526. | ||
</ref> | |||
== Differential Diagnosis == | == Differential Diagnosis == | ||
Revision as of 02:17, 21 December 2023
Original Editor - Rahma Ahmed Ahmed Bahbah
Top Contributors - Rahma Ahmed Ahmed Bahbah
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (21/12/2023)
Introduction[edit | edit source]
Dyslipidemia is characterized by an elevation of low-density lipoprotein cholesterol (LDL-C) and reduced serum high-density lipoprotein cholesterol (HDL-C) concentration.[1]
Differential Diagnosis[edit | edit source]
There are 4 different lipid disorders:
- Dyslipidemia
- Hyperlipidemia
- Hypercholesterolemia
- Hypertriglyceridaemia
To know the difference, check this video
References[edit | edit source]
- ↑ Marques LR, Diniz TA, Antunes BM, Rossi FE, Caperuto EC, Lira FS, Gonçalves DC. Reverse cholesterol transport: molecular mechanisms and the non-medical approach to enhance HDL cholesterol. Frontiers in Physiology. 2018 May 15;9:526.
